Lipella Pharmaceuticals Inc Sustainability Reports
Lipella Pharmaceuticals Inc. is a clinical-stage biotechnology company that focuses on developing and commercializing new drugs by reformulating active agents in existing generic medications. It primarily targets diseases with significant unmet medical needs, such as overactive bladder and common bladder syndromes.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 549300NLVVVRGBF0WG69
FIGI: BBG002GP9146
2 reports from 2022 to 2023
